tradingkey.logo

Quest Diagnostics Inc

DGX
查看详细走势图
184.110USD
+1.550+0.85%
收盘 12/15, 16:00美东报价延迟15分钟
20.44B总市值
21.37市盈率 TTM

Quest Diagnostics Inc

184.110
+1.550+0.85%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+0.85%

5天

+1.26%

1月

-1.52%

6月

+2.16%

今年开始到现在

+22.04%

1年

+18.78%

查看详细走势图

TradingKey Quest Diagnostics Inc股票评分

单位: USD 更新时间: 2025-12-12

操作建议

Quest Diagnostics Inc当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在医疗服务供应商行业排名15/78位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价196.72。中期看,股价处于平稳状态。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Quest Diagnostics Inc评分

相关信息

行业排名
15 / 78
全市场排名
83 / 4592
所属行业
医疗服务供应商

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 20 位分析师
买入
评级
196.716
目标均价
+8.19%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Quest Diagnostics Inc亮点

亮点风险
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
高分红
公司属于高分红公司,最新股息支付率38.22%
稳定分红
公司5年内连续分红,最新股息支付率38.22%
估值高估
公司最新PE估值21.19,处于3年历史高位
私人资本持仓
明星投资者私人资本持仓,最新持仓市值8.70K

Quest Diagnostics Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Quest Diagnostics Inc简介

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
公司代码DGX
公司Quest Diagnostics Inc
CEODavis (James E)
网址https://www.questdiagnostics.com/

常见问题

Quest Diagnostics Inc(DGX)的当前股价是多少?

Quest Diagnostics Inc(DGX)的当前股价是 184.110。

Quest Diagnostics Inc的股票代码是什么?

Quest Diagnostics Inc的股票代码是DGX。

Quest Diagnostics Inc股票的52周最高点是多少?

Quest Diagnostics Inc股票的52周最高点是197.550。

Quest Diagnostics Inc股票的52周最低点是多少?

Quest Diagnostics Inc股票的52周最低点是148.700。

Quest Diagnostics Inc的市值是多少?

Quest Diagnostics Inc的市值是20.44B。

Quest Diagnostics Inc的净利润是多少?

Quest Diagnostics Inc的净利润为866.00M。

现在Quest Diagnostics Inc(DGX)的股票是买入、持有还是卖出?

根据分析师评级,Quest Diagnostics Inc(DGX)的总体评级为买入,目标价格为196.716。

Quest Diagnostics Inc(DGX)股票的每股收益(EPS TTM)是多少

Quest Diagnostics Inc(DGX)股票的每股收益(EPS TTM)是8.616。
KeyAI